Schryber SM - Search Results

1

Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors.

Eder JP, Antman K, Elias A, Shea TC, Teicher B, Henner WD, Schryber SM, Holden S, Finberg R, Chritchlow J, et al. Eder JP, et al. Among authors: schryber sm. J Natl Cancer Inst. 1988 Oct 5;80(15):1221-6. doi: 10.1093/jnci/80.15.1221. J Natl Cancer Inst. 1988. PMID: 3138431

2

High-dose thiotepa alone and in combination regimens with bone marrow support.

Antman K, Eder JP, Elias A, Ayash L, Shea TC, Weissman L, Critchlow J, Schryber SM, Begg C, Teicher BA, et al. Antman K, et al. Among authors: schryber sm. Semin Oncol. 1990 Feb;17(1 Suppl 3):33-8. Semin Oncol. 1990. PMID: 2106166

3

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.

Eder JP, Elias A, Shea TC, Schryber SM, Teicher BA, Hunt M, Burke J, Siegel R, Schnipper LE, Frei E 3rd, et al. Eder JP, et al. Among authors: schryber sm. J Clin Oncol. 1990 Jul;8(7):1239-45. doi: 10.1200/JCO.1990.8.7.1239. J Clin Oncol. 1990. PMID: 2162912

4

Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation.

Graves SW, Eder JP, Schryber SM, Sharma K, Brena A, Antman KH, Peters WP. Graves SW, et al. Among authors: schryber sm. Clin Sci (Lond). 1989 Nov;77(5):501-7. doi: 10.1042/cs0770501. Clin Sci (Lond). 1989. PMID: 2555106

5

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Schryber S, Hunt M, Critchlow J, Schnipper L, et al. Elias AD, et al. J Clin Oncol. 1991 Feb;9(2):320-7. doi: 10.1200/JCO.1991.9.2.320. J Clin Oncol. 1991. PMID: 1846407 Clinical Trial.

6

Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow support.

Shea TC, Antman KH, Eder JP, Elias A, Peters WP, Schryber S, Henner WD, Schoenfeld DA, Schnipper LE, Frei E 3rd. Shea TC, et al. Arch Dermatol. 1988 Jun;124(6):878-84. doi: 10.1001/archderm.124.6.878. Arch Dermatol. 1988. PMID: 3288124

7

High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.

Peters WP, Eder JP, Henner WD, Schryber S, Wilmore D, Finberg R, Schoenfeld D, Bast R, Gargone B, Antman K, et al. Peters WP, et al. J Clin Oncol. 1986 May;4(5):646-54. doi: 10.1200/JCO.1986.4.5.646. J Clin Oncol. 1986. PMID: 3517240

8

Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapy.

Eder JP, Bast RC, Peters WP, Henner D, Sanchez E, Schryber S, Frei E 3rd, Schnipper LE. Eder JP, et al. Cancer Res. 1986 Sep;46(9):4496-9. Cancer Res. 1986. PMID: 3524814

9

High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.

Eder JP, Antman K, Peters W, Henner WD, Elias A, Shea T, Schryber S, Andersen J, Come S, Schnipper L, et al. Eder JP, et al. J Clin Oncol. 1986 Nov;4(11):1592-7. doi: 10.1200/JCO.1986.4.11.1592. J Clin Oncol. 1986. PMID: 3534155

10

High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.

Antman K, Eder JP, Elias A, Shea T, Peters WP, Andersen J, Schryber S, Henner WD, Finberg R, Wilmore D, et al. Antman K, et al. Cancer Treat Rep. 1987 Feb;71(2):119-25. Cancer Treat Rep. 1987. PMID: 3542208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters